Literature DB >> 6600861

[Interaction between various cholinesterases and reversible inhibitors of polymethylene-bis-(trimethylammonium) diiodide series].

A P Brestkin, T N Viniar, E V Rozengart.   

Abstract

It is established that derivatives of polymethylene bistrimethylammonium (CH3)3N+(CH2)nN+(CH3)3 (n = 4-10) are reversible competitive and mixed action inhibitors with respect to acetylcholinesterase of human erythrocytes, butyryl cholinesterase of horse blood serum, cholinesterase of frog brain and Todarodes pacificus optical ganglion. In case of mammals and frog cholinesterase the inhibitors efficiency rises with n, but the activity of the Todarodes pacificus cholinesterase less sensitive of the inhibitors is characterized by a "step" dependence on the length of the polymethylene chain of the inhibitor molecule. Studies in sensitivity of cholinesterases to this type of inhibitors revealed differences between enzymes of the same type in different animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600861

Source DB:  PubMed          Journal:  Ukr Biokhim Zh (1978)        ISSN: 0201-8470


  3 in total

1.  Conformational aspects of the interaction of various cholinesterases with polymethylene-bis(trimethylammonium) derivatives.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2002 Sep-Oct       Impact factor: 0.788

2.  Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.

Authors:  E V Rozengart
Journal:  Dokl Biochem Biophys       Date:  2003 Jan-Feb       Impact factor: 0.788

3.  Elementorganic bisonium reversible inhibitors of different cholinesterases.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2004 Mar-Apr       Impact factor: 0.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.